The guide sequence provides recognition by pairing with a complementary DNA target, while the scaffold forms the structural region that binds the CRISPR-associated protein Cas9. Both parts are required for coordinated targeting: the guide supplies sequence selectivity, and the scaffold supports protein association. This division allows researchers to alter target recognition while retaining Cas9-compatible structural features.
A protospacer adjacent motif, or PAM, is a nearby DNA sequence required for Cas9-compatible targeting. Guide complementarity alone is therefore insufficient if the selected region lacks an appropriate PAM. During design, researchers must consider both the intended complementary sequence and the neighboring PAM, because this combination determines whether Cas9 can act at the chosen genomic site.
Complementarity connects the guide portion of the RNA with the selected nucleic acid sequence, helping determine where the CRISPR-Cas9 system acts. When targeting conditions are met, Cas9 produces a site-specific double-strand break at that location. The selected target therefore influences which gene or regulatory region is modified and what biological question the experiment can address.
Design begins by selecting a nucleic acid region relevant to the research question, identifying a compatible PAM, and specifying a guide sequence complementary to the target. The guide must also be incorporated with the scaffold region that binds Cas9. These choices connect the intended genomic site with the desired experimental purpose, such as gene disruption or sequence insertion.
Depending on the CRISPR system and experimental design, targeting can support gene knockout, targeted sequence insertion, transcriptional regulation, or genome screening. A knockout investigates consequences of disrupting a gene, whereas insertion adds a selected sequence. Regulation changes gene expression without necessarily using the same outcome as a sequence modification, allowing distinct functional questions to be tested.
Their programmable targeting lets researchers examine the effects of altering selected genes or genomic regions in cells and organisms. Experiments can connect a targeted genetic change with gene function, disease mechanisms, or broader biological responses. Genome screening extends this approach across many targets, helping identify genes or sequences associated with a phenotype or process under study.